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Klebsiella pneumoniae porin genes were analyzed to detect mutations accounting for the porin deficiency
observed in many b-lactam-resistant strains. PCR and Southern blot analysis revealed the existence of a third
porin gene in addition to the OmpK36 and OmpK35 porin genes previously described. This new porin gene was
designated ompK37 and is present in all of the clinical isolates tested. The OmpK37 porin gene was cloned,
sequenced, and overexpressed in Escherichia coli. In contrast to that of the major porins, OmpK37 porin
expression was only detectable by Western blot analysis in porin-deficient b-lactam-resistant strains, suggest-
ing strong down regulation under standard laboratory conditions. Functional characterization suggested a
narrower pore for the OmpK37 porin than for K. pneumoniae porins OmpK36 and OmpK35. This correlated
with the susceptibility to certain b-lactam antibiotics, since a K. pneumoniae strain expressing porin OmpK37,
but not porin OmpK36 or OmpK35, was less susceptible to b-lactam antibiotics than the same strain
expressing either porin OmpK36 or OmpK35.
The outer membrane of gram-negative bacteria plays a sig-
nificant role in a variety of functions; it serves as a diffusion
barrier to extracellular solutes and interacts with the bacterial
environment. This membrane is composed of a bilayer con-
taining phospholipids, lipopolysaccharide, and outer mem-
brane proteins (OMPs). One family of OMPs, the porins, are
present in large amounts in the outer membrane and form
water-filled channels that permit the diffusion of small hydro-
philic solutes across the outer membrane. Porins are generally
divided into two classes: nonspecific porins (e.g., OmpC and
OmpF), which permit the general diffusion of small polar mol-
ecules (,600 Da), and specific porins (e.g., LamB), which
facilitate the diffusion of specific substrates.
We have defined two major porins in Klebsiella pneumoniae
designated OmpK36 (3) and OmpK35 (14). Their character-
ization revealed that porins OmpK36 and OmpK35 are the
homologues of porins OmpC and OmpF from Escherichia coli,
respectively. Furthermore, porins OmpK36 and OmpK35 al-
low the diffusion of a wide variety of molecules, including
bacterial nutrients and antimicrobials.
b-Lactam antibiotics are currently used in the treatment of
infections with K. pneumoniae (30). This microorganism is a
major nosocomial pathogen causing pneumonia, urinary tract
infections, and bacteremia, particularly in immunocompro-
mised patients. Antimicrobial treatment is critical for these
patients; however, multiantibiotic-resistant strains emerge fre-
quently in the hospital (20, 25, 27). Resistance to b-lactams is
associated mainly with the expression of plasmid- or chromo-
some-encoded b-lactamases able to inactivate b-lactams. How-
ever, since b-lactam antibiotics penetrate the outer membrane
of many gram-negative bacteria through porins, antibiotic re-
sistance can also be caused by porin loss or deficiency (23).
Porin loss as a mechanisms of antimicrobial resistance has
been described in many species (1, 19). Recently, we demon-
strated that this antimicrobial resistance strategy also operates
in K. pneumoniae (15, 18). In these studies, we isolated clinical
strains resistant to b-lactam antibiotics with a characteristic in
common: they simultaneously lacked expression of the
OmpK35 and OmpK36 porins.
To study the molecular mechanisms causing porin loss in K.
pneumoniae, we PCR amplified the porin genes from porin-
deficient K. pneumoniae clinical isolates. Interestingly, in ad-
dition to the OmpK36 and OmpK35 porin genes, we amplified
a third DNA fragment. Sequence analysis of this unexpected
DNA fragment revealed the existence of a new porin gene in
K. pneumoniae. Functional characterization of this new porin
revealed a narrower pore than those of porins OmpK35 and
OmpK36, which did not allow penetration by certain b-lac-
tams, causing resistance to these antimicrobial agents.
MATERIALS AND METHODS
Strains, plasmids, and media. The K. pneumoniae strains and plasmids used in
this study are indicated in Table 1. Escherichia coli DH5a was used for cloning
experiments. Strains were grown in Luria-Bertani medium supplemented with
50-mg/liter kanamycin or ampicillin when required.
DNA procedures. Plasmid DNA was isolated by using the Wizard Miniprep Kit
(Promega) in accordance with the manufacturer’s instructions. Isolation of
genomic DNA, transformation, and electroporation were carried out by standard
techniques (5). T4 DNA ligase and restriction endonucleases were used by
following the manufacturer’s recommendations (Pharmacia). DNA fragments
prepared by restriction enzyme digestion were separated by agarose gel electro-
phoresis and visualized by ethidium bromide staining. DNA fragments were
recovered from agarose gels by using the Qiaquick gel extraction kit (Qiagen).
Southern blot analysis and probe labeling and detection were carried out by using
the ECL kit (Amersham). OmpK36, OmpK35, and OmpK37 porin gene probes
were obtained from strain SD8 by PCR with primers U681 and L1316. DNA
sequencing was performed by using an automated sequencing apparatus (Ap-
plied Biosystems).
PCR. PCR amplifications were performed in a Thermoline Amplitron 1 ther-
mal cycler by using Taq polymerase (Pharmacia) with 30 cycles of amplification
(1 min at 94°C, 1 min at 55°C, and 1 min at 72°C).
The primers used to amplify porin genes were U681 (59-CGGTTACGGCCA
GTGGGAATA-39) and L1316 (59-GACGCAGACCGAAATCGAACT-39).
They anneal to sequences conserved in both ompK36 and ompK35 located 215
and 850 bp downstream of the ompK36 start codon (3), respectively. Three
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amplicons of about 600, 650, and 700 bp were obtained from strain SD8 with
the above primers and cloned in pGEM-T. Primer INTF (59-GCAGTATCA
GGGCAAAAAC-39), which anneals 506 bp downstream of the ompK36 start
codon, and primer L1316 were used for PCR amplification of plasmids
pSUV7 and pSHA16, containing the cloned ompK36 and ompK35 genes,
respectively (Table 1) and the pGEM-T clone containing the 700-bp amplicon
described above. The amplicons obtained with primers INTF and L1316,
which contain sequences specific for the three porin genes studied, were used
as specific probes for Southern blotting.
The ompK37 gene was amplified without its native promoter using primers
complementary to regions situated in the 59 region (59-CCGGATCCTAAAGC
ATGAGTTC-39) and in the 39 region (59-GGGGATCCGCATCAGAACTGG-
39) of the gene. Restriction sites (BamHI, underlined) were incorporated for
cloning. The primers used to amplify the ompK37 promoter region were L879
(59-CCTGAACGTTGTATTCCCACTG-39) and UP37 (59-CCAAGCTTGACG
GAAAACGTCAA-39). They anneal to sequences located 225 bp downstream
and 933 bp upstream of the ompN start codon (accession no. AF035618), re-
spectively.
Isolation of OMPs and porins. Bacterial cell envelopes containing cytoplasmic
and outer membranes were obtained by French press cell lysis and centrifuga-
tion. OMPs were isolated as sodium lauryl sarcosinate-insoluble material (11).
Porins were isolated as described before (2) by a combination of methods (22,
24). Electrophoretic analysis of OMPs was performed in 11.5% acrylamide–0.5%
bisacrylamide–0.1% sodium dodecyl sulfate (SDS) gels. Samples were boiled for
5 min in Laemmli’s sample buffer before electrophoresis. Coomassie blue-
stained OMP gels were analyzed by densitometry using the Whole Band Ana-
lyzer Program (Bioimage). Purity of the isolated porins was confirmed by SDS-
polyacrylamide gel electrophoresis (PAGE) analysis and N-terminal sequencing
(Applied Biosystems).
OmpK37 porin expression in K. pneumoniae clinical isolates was also analyzed
by Western blotting. For this purpose, SDS-PAGE gels were transferred to
Immobilon-P filters (Millipore) by using the buffers and conditions described by
Towbin et al. (28), except that 1 A was applied for 1 h. Filters were blocked in
1% bovine serum albumin in phosphate-buffered saline (PBS). After washing,
the filters were sequentially incubated with anti-OmpK37 serum (see below)
diluted 1:100 and with alkaline phosphatase-labeled goat anti-rabbit immuno-
globulin G (1:5,000; Sigma). The filters were developed as previously described
(6). All of the incubations were carried out at room temperature for 1 h in 1%
bovine serum albumin–0.05% Tween 20–PBS, and after incubations with the
antiserum, washing steps with 0.05% Tween 20–PBS were performed.
Antiserum. New Zealand rabbits were subcutaneously injected three times
every 2 weeks with 80 mg of purified OmpK37 and bled 2 weeks after the last
injection. To avoid cross-reaction with porins OmpK36 and OmpK35, antiserum
was rendered monospecific (anti-OmpK37) by affinity chromatography on octa-
decyl silica-immobilized OmpK37 (7). Briefly, antiserum was incubated with
octadecyl silica-immobilized OmpK37 overnight at 4°C and poured into a 5-ml
tuberculin syringe plugged with glass wool. To remove nonspecifically bound
antibodies, the column was washed successively with PBS, PBS–5% dioxan, and
PBS. Specific antibodies against OmpK37 were eluted with 0.1 M glycine–0.15 M
NaCl, pH 2.6.
Liposome swelling assay. Liposomes were reconstituted with purified porins as
described previously (17), except that 9.3 mmol of acetone-extracted egg phos-
phatidylcholine, 0.3 mmol of dicetylphosphate, and 3 mg of purified proteins were
used. The rates of sugar diffusion were tested in 5 mM Tris-HCl (pH 7.5) and
15% (wt/vol) dextran T-40.
Susceptibility testing. MICs of antimicrobial agents were determined by mi-
crodilution in accordance with the National Committee for Clinical Laboratory
Standards recommendations (21) with cation-adjusted Mueller-Hinton broth
(Difco). MICs were also determined by using E-test strips in accordance with the
manufacturer’s (AB Biodisk) recommendations.
Nucleotide sequence accession number and homology searches. The sequence
of the K. pneumoniae SD8 ompK37 gene has been deposited in EMBL under
accession no. AJ011502. DNA and protein sequence analyses were performed by
using BLASTN and BLASTP. Pairwise comparisons of mature porin sequences
to obtain their degrees of identity and similarity were performed with the blast
2 sequences tool from the National Center for Biotechnology Information using
the default parameters. These sequences were aligned with ClustalW, analyzed
with Protdist (BIONJ algorithm) (12), and represented with Treeview of the
Phylip package.
RESULTS
Identification, cloning, and sequencing of the ompK37 gene
from K. pneumoniae. In the course of an investigation to detect
and characterize mutations accounting for the loss of porin
expression seen in some antimicrobial-resistant strains, we
PCR amplified internal porin sequences from K. pneumoniae
clinical isolates. Electrophoretic analysis of the PCR amplicons
TABLE 1. Strains and plasmids included in this study
K. pneumoniae strain or plasmid Relevant phenotype Source or reference
Porin-sufficient strainsa
SD8 OmpK361 OmpK351 OmpK372 13
CSUB10S OmpK361 OmpK352 OmpK372 4
Porin-deficient strainsb
CSUB10R OmpK362 OmpK352 OmpK372 4
LB4 OmpK362 OmpK352 OmpK371 18
LB66 OmpK362 OmpK352 OmpK371 15
Plasmids
pBluescript KS(2) High-copy-number cloning vector, Apr Stratagene
pGEM-T PCR fragment cloning vector, Apr Invitrogen
pWSK29 Low-copy-number cloning vector, Apr 29
pCSI2 Kmr cassette-containing vector 9
pSUV7 pACYC184 with cloned ompK36 3
pSHA25K pWSK29 with cloned ompK36 gene and Kmr cassette from pCSI2 This work
pSHA16 pWSK29 with cloned ompK35 Our laboratory
pSHA16K pWSK29 with cloned ompK35 gene and Kmr cassette from pCSI2 This work
pQE1 pWSK29 carrying ompK37-containing EcoRI fragment This work
pQE1K pQE1 with cloned Kmr cassette from pCSI2 This work
pQE3 pBluescript KS(2) carrying ompK37-containing BamHI fragment from pQE1 This work
pQE3K pQE3 with cloned Kmr cassette from pCSI2 This work
pQE7 pWSK29 carrying ompK37 transcribed by lac promoter This work
pQE7K pQE7 with cloned Kmr cassette from pCSI2 This work
pQE31 pBluescript KS(2) containing ompK37 and 700 bp of ompK37 upstream flanking sequence This work
pQE31K pQE31 with cloned Kmr cassette from pCSI2
pQE33 pBluescript KS(2) containing ompK37 and 200 bp of ompK37 upstream flanking sequence This work
pQE33K pQE33 with cloned Kmr cassette from pCSI2 This work
a Porin-sufficient strains are strains expressing either porin OmpK36 or OmpK35 or both.
b Porin-deficient strain are strains lacking expression of porins OmpK36 and OmpK35.
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(Fig. 1A) detected the existence of three DNA fragments in
strain SD8, suggesting the presence of a new porin gene, in
addition to the classical porins OmpK36 and OmpK35 de-
scribed in K. pneumoniae. These results were confirmed by
Southern blot analysis of chromosomal DNA from strain SD8
with specific probes for ompK36, ompK35, and the putative
new porin gene (Fig. 1B). As expected, the ompK36 and
ompK35 probes detected DNA fragments with different sizes,
indicating the existence of two separated porin genes. The
probe for the putative new porin gene detected DNA se-
quences located in chromosomal regions different from those
observed for the ompK36 and ompK35 genes. Together, these
results indicated the existence of a new porin gene in strain
SD8 that we designated ompK37. This new porin gene was
present in all of the K. pneumoniae clinical isolates analyzed, as
we confirmed by Southern blot analysis using the ompK37
probe described above (data not shown). The DNA fragment
corresponding to the ompK37 gene from strain SD8 was cloned
and sequenced. Since the deduced amino acid sequence pre-
dicts the OmpK37 protein to be synthesized with a signal
peptide, the processing site was confirmed by N-terminal pro-
tein sequencing which yielded the sequence AEIYNKDG
NKLDLYGKVD. The mature OmpK37 porin consists of 353
amino acid residues which yield a protein of 39,491 Da. The
comparison between the amino acid sequences of known en-
terobacterial porins and the deduced protein sequence of
OmpK37 clearly supported our previous deduction that
OmpK37 belongs to the porin family. A standard BLASTP
database search revealed that OmpK37 does not belong to the
previously described porin family OmpC, OmpF, PhoE, or
Lc/NmpC (16). Rather, we observed a distinct group of porins
consisting of K. pneumoniae OmpK37 and the recently de-
scribed porins OmpS2 (10) from Salmonella typhi and OmpN
(26) from E. coli. The percentages of identity and similarity of
OmpK37 with the OmpS2 and OmpN porins are 80 and 88%
and 77 and 85%, respectively. In contrast, other closely related
porins from K. pneumoniae presented lower scores of 70 and
78% and 58 and 68% for OmpK36 and OmpK35, respectively.
Based on sequence alignment (Fig. 2) and on the tridimen-
sional structure of the E. coli OmpF porin (8), we predicted the
secondary structure of the OmpK37 porin. It consists of 16
b-strands highly conserved in all porins, eight short periplasmic
turns, and eight highly variable extracellular loops. L3 and L4
are the most- and least-conserved loops in different porins,
respectively; with L4 having an insertion of 16 amino acids in
OmpK37 with respect to OmpF. Both the highly conserved
motif PEFGGD and charged residues R37, R75, R124, and
D106 and E110, which are opposed across the pore in OmpF,
are also present in OmpK37.
Expression of the OmpK37-encoding gene. For the construc-
tion of an OmpK37 expression plasmid, we cloned the corre-
sponding ompK37 DNA fragment from strain SD8 in plasmid
pWSK29, giving plasmid pQE1. Plasmids encoding porins were
tagged with a kanamycin resistance cassette to allow their
cloning and selection in the multiresistant background of
porin-deficient K. pneumoniae CSUB10R. Transformation of
this strain with pQE1K and SDS-PAGE analysis of the OMPs
did not detect any extra protein compared to the OMPs from
strain CSUB10R (Fig. 3). To express and isolate the OmpK37
porin, we overexpressed the ompK37 gene by using two differ-
ent strategies. First, we subcloned from pQE1 a 5-kb BamHI
fragment containing ompK37 in the high-copy-number plasmid
pBluescript, giving plasmid pQE3 (pQE3K). Second, we cloned
ompK37 without its own promoter behind the lac promoter of
pWSK29, giving plasmid pQE7 (pQE7K). In CSUB10R trans-
formed with pQE3K or pQE7K, we detected a new OMP of
about 39 kDa by SDS-PAGE (Fig. 3).
To determine more precisely the limit of the upstream re-
gion required for maximal expression of the OmpK37 porin,
we generated different constructions with DNA fragments in-
cluding the OmpK37-encoding sequence and adjacent chro-
mosomal DNA sequences extending various distances up-
stream of the ompK37 start codon. Each construction was
cloned into K. pneumoniae CSUB10R, and the OMPs were
analyzed by SDS-PAGE and Coomassie blue staining. OmpK37
porin expression was essentially the same for cells harboring
pQE31K, a construct that included DNA sequences extending
approximately 700 nucleotides upstream of the ompK37 start
codon, as for cells with pQE33K, a construct including se-
quences extending 200 nucleotides upstream (Fig. 3). These
results suggest that the entire 235, 210 promoter region re-
quired for maximal expression of OmpK37 is included in the
upstream 200 bp adjacent to the ompK37 start codon.
We investigated the natural OmpK37 porin expression
among clinical isolates. Although the ompK37 gene is present
in all of the K. pneumoniae isolates analyzed, expression of the
OmpK37 porin was not detected by SDS-PAGE and Coomas-
sie blue staining in any isolate. However, we were able to
detect OmpK37 expression by Western blot analysis with anti-
OmpK37 serum in some strains. As shown in Fig. 4, OmpK37
porin expression was detected in porin-deficient (OmpK362
OmpK352) strains LB4 and LB66. However, not all of the
porin-deficient strains studied expressed OmpK37 (e.g., strain
CSUB10R). Furthermore, among 10 porin-sufficient strains
(OmpK361, OmpK351, or both), we did not detect OmpK37
expression. This is the case for strain SD8 (Fig. 4), which was
used to clone ompK37.
To investigate whether the variation in OmpK37 expression
was associated with changes in the promoter region sequence,
we analyzed the nucleotide sequence of this region of the K.
pneumoniae chromosome from strains LB4, LB66, SD8, and
CSUB10R. Comparison of the region extending 200 nucleo-
tides upstream of the ompK37 start codon required for maxi-
mal expression of the porin revealed no nucleotide sequence
differences.
FIG. 1. PCR and Southern blot analysis of the K. pneumoniae SD8 chromo-
some. (A) Resolution by agarose gel electrophoresis of PCR products obtained
by amplification of internal sequences of porin genes from K. pneumoniae SD8
with primers U681 and L1316. The arrow indicates the PCR fragment corre-
sponding to the OmpK37 porin gene. (B) Southern blot analysis of porin genes
ompK36, ompK35, and ompK37 of strain SD8. Chromosomal DNA was digested
with EcoRI, EcoRV, HindIII, and KpnI (from left to right in each panel) and
hybridized with a probe specific for each gene. Molecular masses are indicated in
kilobases on the left for panel A and on the right for panel B.
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Functional characterization of OmpK37: its role in resis-
tance to b-lactam antibiotics. We reconstituted purified porin
OmpK37 into liposomes and studied the rate of sugar perme-
ation (Table 2). Sugar uptake by liposomes containing porin
OmpK37 resembled that by liposomes containing K. pneu-
moniae porins OmpK36 and OmpK35: nonspecific diffusion
through the pore depended on the molecular mass of the
sugar. However, diffusion through OmpK37 was moderately
lower than through porins OmpK36 and OmpK35, suggesting
the existence of a narrower pore in the OmpK37 porin. Assays
with liposomes containing E. coli porins OmpF and OmpC
were performed as controls in our experiments with results
similar to those previously reported in the literature (26) (data
not shown).
Since b-lactam antibiotics pass the outer membrane through
porins, we studied the role of porin OmpK37 in susceptibility
to antimicrobials (Table 3) . We compared the MICs for porin-
sufficient strain K. pneumoniae CSUB10S and the clonally re-
FIG. 2. Alignment of the OmpK37 sequence with selected sequences from other enterobacterial porins from E. coli (porins OmpC, OmpF, OmpN, PhoE, and
NmpC) and S. typhi (OmpS1 and OmpS2). Porins were selected on the basis of their high degree of amino acid identity with OmpK37. Protein sequences were derived
from nucleotide sequences. Secondary-structural motifs are those of the OmpF structure (8).
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lated porin-deficient variant strain CSUB10R (either alone or
transformed with cloned porins). As described before, due to
its porin deficiency, strain CSUB10R is more resistant to b-lac-
tams than is parental strain CSUB10S (4). As expected, for K.
pneumoniae CSUB10R expressing OmpK36 or OmpK35, the
MICs reverted to values similar to those observed for strain
CSUB10S. However, CSUB10R expressing porin OmpK37
from plasmid pQE7K was less susceptible to cefotaxime and
cefoxitin than was CSUB10R expressing either OmpK36 or
OmpK35. These results were not due to differences in porin
expression, since similar levels of expression were achieved
from plasmids pSH25K, pSH16K, and pQE7K, encoding por-
ins OmpK36, OmpK35, and OmpK37, respectively (Fig. 3).
The difference in the MIC for CSUB10R expressing OmpK37
versus OmpK36 or OmpK35 was more pronounced when
CSUB10R was transformed with plasmid pQE1K or pQE3K.
Expression of OmpK37 from these two plasmids is either very
low (pQE3K) or not detectable (pQE1K) by SDS-PAGE anal-
ysis and Coomassie staining (Fig. 3). Under those circum-
stances, MICs are very similar to those for CSUB10R. In
contrast, MICs of meropenem and imipenem, which are small
zwitterionic compounds, were similar to those for the original
sensitive strain, independently of the porin expressed. Only
when OmpK37 was expressed in low amounts (pQE1K and
pQE3K) were the meropenem and imipenem MICs close to
those observed for resistant strain CSUB10R. In summary,
CSUB10R encoding the OmpK37 porin was less susceptible to
certain b-lactam antibiotics than were clonally related strains
encoding OmpK35 or OmpK36, suggesting lower penetration
of those antibiotics through OmpK37.
DISCUSSION
Porins play a crucial role in the interactions between the
environment and bacteria. In addition, or probably as a con-
sequence, they are present in large amounts in the outer mem-
brane of gram-negative bacteria. Since E. coli major porins
OmpC and OmpF were defined, a large number of OmpC- or
OmpF-type porins have been described in other enterobacte-
rial species. We reported the existence of two major porins,
OmpK36 and OmpK35, in K. pneumoniae. They are homolo-
gous to OmpC and OmpF, and they are expressed in large
amounts in most K. pneumoniae clinical isolates independently
of the isolation source (13).
We focused our attention on the role of these porins in
penetration by antibiotics. As has been reported for other
species, porin loss is an important cause of resistance to some
antimicrobials, particularly b-lactam antibiotics (23). This phe-
nomenon was clearly shown by us in K. pneumoniae both in
vitro and in vivo (15, 18). As a result of these investigations, we
isolated clinical strains resistant to most of the b-lactam anti-
biotics currently used to treat K. pneumoniae infections. These
isolates had a characteristic in common: they simultaneously
lacked expression of porins OmpK35 and OmpK36. To char-
acterize the mutations causing loss of porin expression and also
to identify putative new porins that may replace the functions
of the lost porins, we scrutinized the K. pneumoniae genome.
FIG. 3. SDS-PAGE analysis of OMPs isolated from strain CSUB10R and
strain CSUB10R expressing different K. pneumoniae porins. Purified OMPs (5
mg) from strain CSUB10R and its derived clones carrying plasmids pQE1K,
pQE3K, pQE7K, pQE31, pQE33, pSHA16K, and pSHA25K (form left to right,
lanes 1, 2, 3, 4, 5, 6, 7, and 8, respectively) were resolved by SDS-PAGE,
Coomassie blue stained, and analyzed by densitometry. The porin expressed by
each clone is indicated at the top of each lane. Densitometric analysis results for
the corresponding porin are indicated in arbitrary units at the bottom of each
lane and are the mean 6 the standard deviation of at least three independent
experiments. Purified OmpK37 is shown in lane 9. ND, not detected.
FIG. 4. Western blot analysis of OmpK37 expression using monospecific
antiserum. K. pneumoniae SD8, LB4, LB66, and CSUB10R were subjected to
porin isolation methods, and the resulting materials were analyzed in lanes 2 to
5, respectively. Purified porins OmpK37, OmpK36, and OmpK35 were included
as controls in lanes 1, 6, and 7, respectively. Molecular masses in kilodaltons are
indicated on the left.
TABLE 2. Rates of sugar permeation through various
K. pneumoniae porins
Sugar Molwt
Mean rate 6 SDa
OmpK37 OmpK36 OmpK35
Galactose 180.2 72.3 6 4.2 88.0 6 2.2 91.8 6 2.3
Mannose 180.2 49.3 6 3.2 84.0 6 3.2 61.9 6 1.3
GluNAc 221.1 29.6 6 0.9 44.2 6 6.4 42.0 6 4.2
Lactose 360.3 NDb ND 5.1 6 1.3
Trehalose 378.3 ND ND ND
a Expressed as a percentage of the value for arabinose. Standard deviations
correspond to at least five measurements with four different liposome prepara-
tions.
b ND, not detectable by the method used.
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We identified, cloned, and sequenced a new porin gene that
was designated ompK37. The amino acid sequence revealed
that this new porin of K. pneumoniae is highly homologous to
porins OmpS2 from S. typhi and OmpN from E. coli. Both
OmpS2 and OmpN were previously described as quiescent
porins (10, 26). They were not detected in the outer membrane
of strains grown under standard laboratory conditions. Fur-
thermore, OmpN was overexpressed in order to isolate it and
characterize its pore properties (26). In our case, OmpK37
expression was detected by a more sensitive analysis. However,
OmpK37 was not detected in all of the strains tested. Among
all of the clinical isolates analyzed, OmpK37 expression was
detected preferentially in porin-deficient strains. OmpK37
porin overexpression was also achieved through the lac pro-
moter. Together, the results obtained with porins OmpK37,
OmpS2, and OmpN indicate that in the enterobacterial species
in which these porin genes have been detected, they are sub-
jected to strong down regulation. Regulation most probably
occurs at the transcriptional level and by trans-acting mecha-
nisms, since promoter substitution causes overexpression of
ompK37. In addition, we have shown that the 200-bp nucleo-
tide sequence immediately upstream of the start codon is suf-
ficient for maximal expression of the OmpK37 porin. This
region was identical among strains expressing or not expressing
OmpK37, suggesting the possibility that the trans-acting fac-
tor(s) may influence ompK37 transcription by interacting with
sequences further upstream.
Porins OmpK37, OmpS2, and OmpN are not expressed or
are expressed at very low levels under standard laboratory
conditions. However, these porins may be expressed under
other conditions, and under these circumstances, we still do
not know about their possible roles. In previous reports, no
functions were attributed to the quiescent porins mentioned.
Since OmpK37 expression was detected mainly in porin-defi-
cient b-lactam-resistant strains, we decided to characterize its
possible role in permeation by b-lactams.
For this purpose, we expressed similar amounts of each K.
pneumoniae porin (OmpK37, OmpK36, or OmpK35) on the
outer membrane of a porin-deficient clinical isolate expressing
b-lactamases. MICs of b-lactam antibiotics were higher for the
strain that expressed OmpK37 than for those that expressed
OmpK36 or OmpK35. This phenomenon was particularly rel-
evant with cefotaxime and cefoxitin, the MICs of which were
similar to those for the resistant strain. The molecular masses
of cefotaxime and cefoxitin and their charges allow them to
penetrate the outer membrane more efficiently through the
OmpK36 and OmpK35 porins than through OmpK37, suggest-
ing narrower pore for this new porin. Similar conclusions may
be deduced from the sugar penetration experiments, in con-
trast to the results obtained by Prilipov et al. (26), who re-
ported that sugar diffusion through OmpN was similar to that
through OmpF and OmpC. However, we believe that porin
expression in the natural host (K. pneumoniae) and MIC de-
termination represent a biological phenomenon more repre-
sentative than the liposome swelling assays, where porin prop-
erties may be altered (30). A detailed comparison between the
OmpK36 three-dimensional structure and the predicted
OmpK37 secondary structure revealed an insertion of one
bulky residue (Tyr-118) located in loop 3 of OmpK37. Since
loop 3 is involved in the formation of the pore, this insertion
may contribute to the narrower pore of OmpK37.
Meropenem and imipenem belong to the carbapenem anti-
biotic class. They are zwitterionic compounds, and their mo-
lecular masses are lower than those of the b-lactams cefoxitin
and cefotaxime. These antibiotics are more active than the
b-lactams described above against porin-deficient strains. In
our experiments, MICs of carbapenems did not vary between
strains expressing different porins. Our data supports the idea
that treatment with b-lactam antibiotics can select strains de-
ficient in high-expression porins OmpC and OmpF (or OmpK36
and OmpK35 in K. pneumoniae). In these strains, expression of
quiescent porins or alternative porins like OmpK37, which
essentially allows penetration by carbapenems but not other
b-lactams, may explain why many strains resistant to b-lactams
can still be treated with carbapenems. In concordance with
these findings, we have detected expression of OmpK37 in
strains deficient in porins OmpK36 and OmpK35, although we
could not detect its expression in all of the porin-deficient
strains studied. It is also possible that, in some strains, down-
regulation or even loss of OmpK37 may lead to an increase in
the levels of resistance to carbapenems. The MICs obtained
with strains expressing low amounts of OmpK37 support this
hypothesis.
In summary, we have identified and characterized a new
porin of K. pneumoniae. Its expression is very low under stan-
dard laboratory conditions. However, OmpK37 expression may
be stimulated under conditions (e.g., antibiotic pressure) in
which its functional characteristics (a narrower pore) may be
advantageous over those of the “classical” OmpC-OmpF-type
porins. Under these circumstances, OmpK37 may function as a
porin for the uptake of substrates in strains that lack OmpK35
and OmpK36 as a result of selection for b-lactam resistance. A
better characterization, currently in progress in our laboratory,
of the OmpK37 expression regulatory mechanisms, will im-
prove our knowledge of its role in resistance or sensitivity to
antibiotics.
TABLE 3. MICs of b-lactam antibiotics for clonally related K. pneumoniae strains expressing different porins
Strain Plasmid Porin phenotypea Porin expressionb
MIC (mg/ml)c of:
CTX FOX MP IP
CSUB10S OmpK361 OmpK352 OmpK372 4 2 0.06 0.125
CSUB10R OmpK362 OmpK352 OmpK372 512 128 2 0.5
CSUB10R pSHA25K OmpK361 OmpK352 OmpK372 High 4 2 0.06 0.06
CSUB10R pSHA16K OmpK362 OmpK351 OmpK372 High 4 4 0.12–0.06 0.06
CSUB10R pQE1K OmpK362 OmpK352 OmpK371 Not detectable 512 64 2 0.25
CSUB10R pQE3K OmpK362 OmpK352 OmpK371 Low 256 64–32 2 0.25
CSUB10R pQE7K OmpK362 OmpK352 OmpK371 High 128 32 0.06 0.125
a Analyzed by SDS-PAGE and Coomassie blue staining. In strain CSUB10R(pQE1K), OmpK37 expression was detected by Western blot analysis with anti-OmpK37
serum. Plasmid-encoded porins are in boldface.
b The level of each expressed porin from the corresponding plasmid was determined by SDS-PAGE analysis and Coomassie blue staining (Fig. 3).
c CTX, cefotaxime; FOX, cefoxitin; M, meropenem; IP, imipenem.
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